Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The U3 and Env Proteins of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Both Contribute to Tissue Tropism.

Tytuł:
The U3 and Env Proteins of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Both Contribute to Tissue Tropism.
Autorzy:
Rosales Gerpe MC; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
van Lieshout LP; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Domm JM; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Ingrao JC; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Datu J; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Walsh SR; McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton ON L8S 4L8, Ontario, Canada.
Yu DL; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Jong J; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Krell PJ; Department of Cellular and Molecular Biology, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Wootton SK; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph ON N1G 2W1, Ontario, Canada.
Źródło:
Viruses [Viruses] 2019 Nov 14; Vol. 11 (11). Date of Electronic Publication: 2019 Nov 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
MeSH Terms:
Terminal Repeat Sequences*
Viral Tropism*
Gene Products, env/*genetics
Jaagsiekte sheep retrovirus/*physiology
Oncogenic Viruses/*physiology
Pulmonary Adenomatosis, Ovine/*virology
Tumor Virus Infections/*virology
Animals ; Cell Line ; Gene Order ; Genome, Viral ; Host Specificity ; Host-Pathogen Interactions ; Humans ; Reassortant Viruses/genetics ; Sheep
References:
J Virol. 2008 Sep;82(18):9023-34. (PMID: 18632865)
J Virol. 2006 Aug;80(16):8069-80. (PMID: 16873263)
Nature. 2005 Apr 14;434(7035):904-7. (PMID: 15829964)
Virology. 2007 Dec 5;369(1):119-30. (PMID: 17719071)
Retrovirology. 2015 Apr 09;12:31. (PMID: 25889156)
Vet Res. 2013 Jul 30;44:66. (PMID: 23899161)
J Virol. 2007 Apr;81(8):4052-7. (PMID: 17287273)
J Biol Chem. 2009 Nov 27;284(48):33495-508. (PMID: 19783662)
J Virol. 2016 Aug 26;90(18):8074-84. (PMID: 27356903)
Clin Otolaryngol Allied Sci. 1999 Feb;24(1):67-8. (PMID: 10196653)
Sci Rep. 2017 Aug 16;7(1):8322. (PMID: 28814733)
Genet Mol Res. 2016 Aug 29;15(3):. (PMID: 27706644)
Nature. 2011 Nov 30;481(7379):81-4. (PMID: 22139420)
J Virol. 2005 Jan;79(2):927-33. (PMID: 15613321)
J Virol. 1999 Apr;73(4):2832-40. (PMID: 10074131)
Stem Cells Int. 2015;2015:640218. (PMID: 26273306)
Biochim Biophys Acta. 1989 Jan 17;1010(1):1-6. (PMID: 2642388)
Virology. 2002 Jan 5;292(1):87-97. (PMID: 11878911)
J Virol. 1999 Dec;73(12):10070-8. (PMID: 10559321)
Mol Ther Methods Clin Dev. 2018 Apr 14;9:323-329. (PMID: 30038936)
J Virol. 1993 Jan;67(1):112-8. (PMID: 7677952)
Virology. 2010 Mar 30;399(1):23-30. (PMID: 20110097)
Retrovirology. 2006 Dec 19;3:94. (PMID: 17177996)
Semin Cancer Biol. 2008 Aug;18(4):296-301. (PMID: 18485731)
Antiviral Res. 2015 Aug;120:101-11. (PMID: 26022197)
Virology. 2005 Jul 20;338(1):144-53. (PMID: 15950254)
J Gen Virol. 2006 Sep;87(Pt 9):2685-92. (PMID: 16894209)
J Virol. 2008 Mar;82(5):2543-54. (PMID: 18094165)
Nat Biotechnol. 2001 Mar;19(3):225-30. (PMID: 11231554)
J Virol. 2011 Aug;85(15):7535-45. (PMID: 21593165)
Cell Mol Life Sci. 2008 Nov;65(21):3422-32. (PMID: 18818869)
Mol Ther Methods Clin Dev. 2018 Aug 04;10:245-256. (PMID: 30112421)
Immunol Res. 1998;17(1-2):209-16. (PMID: 9479582)
J Biol Chem. 2004 Jun 25;279(26):26991-7007. (PMID: 15090545)
Biol Reprod. 2005 Aug;73(2):271-9. (PMID: 15788753)
Virol J. 2016 Dec 30;13(1):209. (PMID: 28038674)
J Virol. 1988 Dec;62(12):4828-31. (PMID: 2846895)
J Virol. 2003 Mar;77(5):2850-8. (PMID: 12584308)
J Virol. 2011 Jul;85(14):7118-28. (PMID: 21593182)
J Virol. 2004 Oct;78(20):11130-41. (PMID: 15452233)
Proc Natl Acad Sci U S A. 1986 May;83(10):3376-80. (PMID: 3010293)
Curr Top Microbiol Immunol. 1984;112:21-44. (PMID: 6090060)
Cell Immunol. 1994 Dec;159(2):331-9. (PMID: 7994765)
J Virol. 2002 Oct;76(20):10211-8. (PMID: 12239296)
J Gen Virol. 2014 Aug;95(Pt 8):1843-54. (PMID: 24836673)
Am J Respir Crit Care Med. 2012 Nov 1;186(9):846-56. (PMID: 22955314)
Nucleic Acids Res. 1984 Aug 24;12(16):6427-42. (PMID: 6089114)
Biochem Biophys Res Commun. 2011 Jul 22;411(1):175-9. (PMID: 21740893)
J Virol. 2002 Jun;76(11):5387-94. (PMID: 11991967)
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4443-8. (PMID: 11296287)
Viruses. 2014 Jan 16;6(1):284-300. (PMID: 24441863)
BMC Res Notes. 2016 Jan 07;9:15. (PMID: 26744306)
Viruses. 2014 Dec 09;6(12):4926-45. (PMID: 25502326)
Biotechniques. 2010 Jun;48(6):463-5. (PMID: 20569222)
PLoS One. 2014 Apr 10;9(4):e94595. (PMID: 24722238)
Nat Med. 2006 Aug;12(8):967-71. (PMID: 16845388)
Matrix Biol. 2015 Oct;48:42-54. (PMID: 25864644)
J Virol. 2005 Jan;79(1):87-94. (PMID: 15596804)
J Virol. 2006 Sep;80(18):9322-5. (PMID: 16940543)
J Gen Virol. 1996 Dec;77 ( Pt 12):2991-8. (PMID: 9000089)
J Virol. 2000 Jul;74(13):5776-87. (PMID: 10846056)
PLoS Pathog. 2011 Mar;7(3):e1002014. (PMID: 21483485)
J Immunol. 1989 Aug 1;143(3):787-92. (PMID: 2473110)
Int J Cancer. 2002 Feb 1;97(4):416-24. (PMID: 11802201)
J Infect Dis. 2001 Dec 1;184(11):1423-30. (PMID: 11709784)
J Virol. 2006 Jan;80(1):332-41. (PMID: 16352558)
Biol Reprod. 2014 Nov;91(5):109. (PMID: 25232017)
Eur Respir J. 1998 Feb;11(2):330-3. (PMID: 9551733)
Viruses. 2010 Sep;2(9):2000-12. (PMID: 21274409)
J Gen Virol. 2017 Jan;98(1):108-120. (PMID: 27902399)
J Virol. 1999 Aug;73(8):6964-72. (PMID: 10400795)
Osteoarthritis Cartilage. 2006 Dec;14(12):1312-4. (PMID: 17011800)
Virus Genes. 2007 Oct;35(2):303-12. (PMID: 17268841)
Biomacromolecules. 2008 Jun;9(6):1535-40. (PMID: 18452332)
J Virol. 2002 Mar;76(5):2141-9. (PMID: 11836391)
Viruses. 2010 Dec;2(12):2618-48. (PMID: 21994634)
Gene Ther. 2012 Feb;19(2):201-9. (PMID: 21654824)
Virus Res. 2010 Jul;151(1):74-87. (PMID: 20398709)
Contributed Indexing:
Keywords: chimeric virus; envelope glycoproteins; long terminal repeat (LTR), sheep betaretroviruses; pathogenesis; pseudotyping; tropism
Substance Nomenclature:
0 (Gene Products, env)
Entry Date(s):
Date Created: 20191120 Date Completed: 20200916 Latest Revision: 20200916
Update Code:
20240104
PubMed Central ID:
PMC6893448
DOI:
10.3390/v11111061
PMID:
31739606
Czasopismo naukowe
Jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV) are small-ruminant betaretroviruses that share high nucleotide and amino acid identity, utilize the same cellular receptor, hyaluronoglucosaminidase 2 (Hyal2) for entry, and transform tissues with their envelope (Env) glycoprotein; yet, they target discrete regions of the respiratory tract-the lung and nose, respectively. This distinct tissue selectivity makes them ideal tools with which to study the pathogenesis of betaretroviruses. To uncover the genetic determinants of tropism, we constructed JSRV-ENTV chimeric viruses and produced lentivectors pseudotyped with the Env proteins from JSRV (Jenv) and ENTV (Eenv). Through the transduction and infection of lung and nasal turbinate tissue slices, we observed that Hyal2 expression levels strongly influence ENTV entry, but that the long terminal repeat (LTR) promoters of these viruses are likely responsible for tissue-specificity. Furthermore, we show evidence of ENTV Env expression in chondrocytes within ENTV-infected nasal turbinate tissue, where Hyal2 is highly expressed. Our work suggests that the unique tissue tropism of JSRV and ENTV stems from the combined effort of the envelope glycoprotein-receptor interactions and the LTR and provides new insight into the pathogenesis of ENTV.
Competing Interests: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies